Brief description of measure CMS125: Breast Cancer Screening: Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the Measurement Period. CMS153: Chlamydia Screening in Women: Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period. CMS165: Controlling High Blood Pressure: Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled (<140/90mmHg) during the measurement period. Description of issue ​The measure developer received feedback to incorporate timing requirements in the header narrative to improve alignment between the header and the logic expression. Goal of review Obtain clinical feedback

Proposed solution ​​//CMS125// Denominator Exclusions before: Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy. Denominator Exclusions after: Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy on or before the end of the measurement period. //CMS153// Description before: Percentage of women 16-24 years of age who were identified as sexually active [...] Description after: Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period [...] Denominator Exclusions before: Women who are only eligible for the initial population due to a pregnancy test [...] Denominator Exclusions after: Women who are only eligible for the initial population due to a pregnancy test during the measurement period [...] //CMS165// Initial Population before: Patients 18-85 years of age by the end of the measurement period who had a visit and diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period Initial Population after: Patients 18-85 years of age by the end of the measurement period who had a visit during the measurement period and diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period Rationale for change ​The change is proposed to improve clarity about the timing requirements in the header narrative.